Conference Resources | Abstracts
September 3
rd
– 6
th
, 2014 | Toronto, Canada |
268
Poster Tour 23: Epidemiology III
P182
Screening intervals for coeliac disease in youth with type 1 diabetes: systematic review
A. Pham-Short
1,2
, K.C. Donaghue
1,2
, G. Ambler
1,2
, H. Phelan
3
, S. Twigg
2,4
, M.E. Craig
1,2,5
1
The Children's Hospital at Westmead, Institute of Endocrinology and Diabetes, Sydney, Australia,
2
The University of Sydney, Sydney, Australia,
3
John Hunter Children's Hospital, Newcastle, Australia,
4
Royal Prince Alfred Hospital, Sydney, Australia,
5
University of New South Wales, Sydney, Australia
Objectives:
To systematically review the incidence and prevalence of coeliac disease (CD) in type 1
diabetes (T1D) and determine the optimal screening frequency for CD.
Methods:
Systematic review of longitudinal cohort studies screening for coeliac autoimmunity in T1D.
Outcomes examined were: prevalence, incidence and cumulative incidence of biopsy proven CD. Data
sources included MEDLINE, EMBASE and the Cochrane Library to 31 Dec 2013.
Results:
402 non-duplicate citations were identified, with 45 studies selected for full-text review. Nine
longitudinal cohort studies met the inclusion criteria involving 11,156 young people aged < 21 years at
diabetes diagnosis. No adult studies were identified. Median follow up was 6 years, range 1 - 18 years.
The proportion of patients screened declined from 50% at the end of year 1 to 35% (p< 0.001) at the
end of year 5, and 12% at the end of year 10 suggesting under ascertainment of cases by the
investigators. There were 587 cases of biopsy-proven CD of whom 41 were diagnosed prior to T1D
[pooled prevalence 5.3%, 95% CI (4.8 - 5.7)]. Of the remaining 546 CD cases, 40% were diagnosed
within 1 year of T1D, 55% within 2 years and 79% within 5 years of T1D [median age at CD diagnosis
was 9.7 years [IQR 9.4 - 10.7]. Cumulative incidence was 19.8 per 1,000 patient years at 1 year, 26.8
at 2 years and 40.0 at 5 years.
Conclusions:
CD is relatively common in young persons under 21 years of age with T1D; the risk is
greatest within 2 years of diabetes onset but 21% are diagnosed after more than 5 years diabetes
duration. We recommend screening at diabetes diagnosis, annually for the first 2 years, and again at
least once before 5 years of diabetes duration. Whilst CD can be diagnosed beyond 10 years after
diabetes diagnosis, more research is required to establish the optimal screening frequency beyond 5
years of diabetes duration as well as the optimal screening frequency in adults with T1D.